Extraction and characterization of nanocellulose from waste of date palm "Phoenix dactylifera″ as reinforcement of polymer composites.

The cellulose is the most abundant and renewable polymer in nature. It is characterized by its biodegradability that can help to establish a friendly environment. The main objective of this study is intended to characterize the nanocellulose obtained from waste date palm,  including the dried palms (DP) and the fresh palms (FP) by implementing chemical methods (hydrolysis with H2SO4). Physical properties, morphology, the elemental composition and the thermal stability were determined by Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), zeta sizer, scanning electron microscopy (SEM), whereas energy dispersive X-ray (EDX) and thermogravimetric analysis (TGA), respectively. FTIR, SEM and EDX results, revealed the effective removal of impurities, hemicellulose and lignin. Palm sample residues contained 35.99% of cellulose and 33.12% of cellulose nanocrystals (CNC) for DP, and 36.17% of cellulose and 34.35% of CNC for FP. The CNCs have higher crystallinity than the raw fibers and Zeta sizer was between 25 and 1150 nm. TGA analysis showedthat DP exhibited greater thermal resistance.

COVID-19 Vaccines and Roles of the Health Regulatory Authority in Tunisia.

Given the unstoppable spread of coronavirus disease (COVID-19), the development of a vaccine was needed to contain the pandemic. In such a situation of global emergency, regulatory authorities ensured timely, safe, and equitable access to the vaccine.This article aims to outline the roles of the Tunisian regulatory authority, the Directorate of Pharmacy and Medicines (DPM) at the Ministry of Health, in registration and procurement of the COVID-19 vaccine.Requirement to grant the Exceptional Provisional Authorizations of Marketing (EPAM) for COVID-19 vaccines was 27 days versus 869 days for conventional marketing authorizations (MAs). The DPM has optimized its activity through: early dialogue with manufacturers, online submission, the use of distance communication technologies. It has demonstrated unprecedented flexibility through the continuous and rolling review approach.Regulatory authorities in Tunisia and around the world have partnered with manufacturers to speed up administrative procedures while ensuring the quality, safety, and efficacy of vaccines.

Regulatory Challenges in the COVID-19 Era: The Case of Tunisia.

In view of the possible disruptions in the manufacturing and supply of health products following the coronavirus disease 2019 (COVID-19) pandemic, the Tunisian medicines regulatory authority was mobilized to guarantee patient safety. Teleworking has become the ultimate way of service continuity. The planning was revised according to health priorities. Work procedures were set online. A minimum list of medicines known as "medicines of health and strategic interest" was established. The Directorate of Pharmacy and Medicines (DPM) has been working on updating medicines stock data. A provisional suspension of authorizations for medicines export for 1 mo was decided. A fast-track procedure allowing the validation of alternative sources of raw materials has been put in place. An appeal for a fast track manufacture of hydroalcoholic gel/solutions was launched. A Monitored Emergency Use of Unregistered and Investigational Interventions (MEURI) procedure has been adopted in order to dispense off-label prescriptions of hydroxychloroquine and azithromycin combination. Focus groups were organized in order to set up therapeutic trials exploring possible strategies of COVID-19 treatment, such as serotherapy and BCG vaccine. This proactive and anticipatory policy has made it possible to meet the health challenges dictated by this crisis.